The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Perlamutrov Iu.N.

GBOU VPO "Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet im. A.I. Evdokimova"

Glazkova Iu.P.

Moscow State Medical Stomatological University

Tereshchenko A.V.

Kaluzhskiĭ filial FGBU "MNTK "Mikrokhirurgiia glaza" im. akad. S.N. Fedorova" Minzdrava Rossii

Vikha G.V.

Moscow State Medical Stomatological University

Evaluation of efficiency and tolerability of immunosuppressive therapy for the combined treatment of lichen rubber planus affecting oral cavity mucosa

Authors:

Perlamutrov Iu.N., Glazkova Iu.P., Tereshchenko A.V., Vikha G.V.

More about the authors

Read: 1311 times


To cite this article:

Perlamutrov IuN, Glazkova IuP, Tereshchenko AV, Vikha GV. Evaluation of efficiency and tolerability of immunosuppressive therapy for the combined treatment of lichen rubber planus affecting oral cavity mucosa. Russian Journal of Clinical Dermatology and Venereology. 2010;8(4):40‑44. (In Russ.)

Recommended articles:
Features of the course of pregnancy in patients with apla­stic anemia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):15-21

References:

  1. Bucci E., Mignogna Michele D., Fedele Stefano et al. Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 2004; 40: 2: 120-130.
  2. Dissemond J. Oral lichen planus: an overview. J Dermatolog Treat 2004; 15: 136-140.
  3. Eisen D. et al. Oral lichen planus: clinical features and management. Oral Dis 2005; 11: 338.
  4. Rhodus N.L., Cheng B., Ondrey F. Th1/Th2 cytokine ratio in tissue transudates from patients with oral lichen planus. Mediators Inflamm 2007; 2007: 19 854.
  5. Vikha G.V., Serdyuk O.A., Papazov I.P. Sekretornyi immunoglobulin A i ego znachenie v diagnostike patologii. V kn.: Biotekhnologiya - sostoyanie i perspektivy razvitiya. Ch. 1. M 2003; 65.
  6. Anbar T.E., Barakat M., Ghannam S.F. A clinical and epidemiological study of lichen planus. J Dermatolog Treat 2005; 13: 95-99.
  7. Carrozzo M., Uboldi de Capai M., Dametto E. et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 2004; 122: 87-94.
  8. Allik E.L. Sovershenstvovanie lecheniya razlichnykh form ploskogo lishaya slizistoi obolochki polosti rta s uchetom psikhologicheskogo statusa bol'nykh: Avtoref. dis ... kand. med. nauk.
  9. Vikha G.V., Papazov I.P., Volozhin A.I. Sekretornyi immunoglobulin A (sIgA) v dokazatel'noi laboratornoi diagnostike. Netraditsionnye prirodnye resursy, innovatsionnye tekhnologii i produkty. 2005; 13: 89-102.
  10. Rabinovich O.F., Pinegin B.V., Rabinovich I.M., Razzhevina I.V. Sovremennye vozmozhnosti immunokorrigiruyushchei terapii zabolevanii slizistoi obolochki rta. Klin stomatol 2002; 1:
  11. Manolache L., Seceleanu-Petrescu D., Benea V. Lichen planus patients and stressful events. J Eur Acad Dermatol Venerol 2008; 22: 437-441.
  12. Tsvetkova L.A., Arutyunov S.D., Petrova L.V., Perlamutrov Yu.N. Zabolevanie slizistoi obolochki rta i gub. M: MEDpress-inform 2005; 208.
  13. Ingafou M. et al. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis 2006; 10: 335-340.
  14. Sugerman P.B., Savage N.W., Walsh L.J. et al. The pathogenesis of oral lichen planus. Oral Dis 2002; 17: 287-293.
  15. Vikha G.V. Sekretornyi immunoglobulin A - marker stressa i neblagopriyatnykh faktorov okruzhayushchei sredy. V kn.: Mezhdunarodnyi ekologicheskii forum. M 2001; 138-140.
  16. Ivanova E.V., Shcherbakova E.G., Rabinovich O.F. i dr. Sovremennye podkhody k patogeneticheskoi terapii ploskogo lishaya slizistoi obolochki polosti rta. Klin stomatol 2005; 5: 33-37.
  17. Petrova L.V. Klinika, patogenez i lechenie krasnogo ploskogo lishaya slizistoi obolochki polosti rta: Avtoref. dis. ... d-ra med nauk. M 2002.
  18. Petrova L.V., Il'ina L.V. Mestnoe primenenie tsiklosporina A v terapii razlichnykh klinicheskikh form krasnogo ploskogo lishaya slizistoi obolochki rta. 2002.
  19. Sugerman P. Oral Lichen Planus. Clinical Science Manager, Abbott Immunology. Abbott Laboratories 2001.
  20. Silverman S., Jr, Gorsky M., Lozada-Nur F. and Giannoti K. A retrospective study of findings and management in 214 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1991; 72: 665-670.
  21. Juneja M. et al. Histochemical analysis of pathological alterations in oral lichen planus and oral lichenoid lesions. J Oral Sci 2006; 4: 185.
  22. Sklavounou-Andrikopoulou A., Chrysomali E., Iakovou M. et al. Elevated serum levels of the apoptosis related molecules TNF-alpha, Fas/Apo-1 and Bcl-2 in oral lichen planus. J Oral Pathol Med 2004; 33: 386-390.
  23. Chuang T.Y., Stitle L., Brashear R., Lewis C. Hepatitis C virus and lichen planus: A case-control study of 340 patients. 2001.
  24. Thornhill M.H. Immune mechanisms in oral lichen planus. Acta Odontol Scand 2001; 59: 174-177.
  25. Timodepressin. Opyt primeneniya v dermatologii. M: Tsentr "Peptos" 2008.
  26. Barret A.W., Cruchley A.T., Williams D.M. Oral mucosal Langerhans' cells. Oral Oncol 2004; 40: 2: 120-130.
  27. Lodi G., Olsen I., Piattelli A. et al. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection. J Oral Pathol Med 2005; 26: 36-39.
  28. Petrova L.V. Osobennosti klinicheskogo techeniya krasnogo ploskogo lishaya slizistoi obolochki polosti rta. Ros zhurn kozh i ven bol 2002; 3: 28-31.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.